Tegaserod [`Zelmac'; Novartis] has been approved in Australia
Source: Inpharma, Volume 1, Number 1325, 2002 , pp. 22-22(1)
Publisher: Adis International
Keywords: Development-status; Irritable-bowel-syndrome, treatment; Product-approvals; Tegaserod, therapeutic use
Language: English
Document Type: Short communication
Publication date: 2002-01-01
- In this: publication
- By this: publisher
- In this Subject: Pharmacology

Shopping cart
Receive new issue alert
Get Permissions